Agios Pharmaceuticals Inc...

NASDAQ: AGIO · Real-Time Price · USD
37.45
0.44 (1.19%)
At close: Aug 18, 2025, 3:59 PM
37.39
-0.16%
After-hours: Aug 18, 2025, 06:03 PM EDT

Agios Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
76.25M 88.2M 139.26M 203.13M
Short-Term Investments
817.46M 688.72M 643.86M 816.89M
Long-Term Investments
638.32M 29.43M 313.87M 266.38M
Other Long-Term Assets
4.72M 4.06M 3.96M 2.9M
Receivables
4.11M 2.81M 2.21M 4.38M
Inventory
27.62M 19.08M 8.49M 16.19M
Other Current Assets
40.16M 35.02M 38.95M n/a
Total Current Assets
965.6M 833.84M 832.77M 1.06B
Property-Plant & Equipment
54.55M 69.79M 88.12M 104.23M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
697.6M 103.28M 405.95M 373.5M
Total Assets
1.66B 937.12M 1.24B 1.44B
Account Payables
16.64M 9.78M 18.62M 16.7M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
46.86M 23.23M 12.24M 12.15M
Total Current Liabilities
81.16M 67.95M 62.63M 59.83M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
41.09M 1.16M 3.28M n/a
Total Long-Term Liabilities
41.09M 58.14M 75.28M 85.94M
Total Liabilities
122.24M 126.1M 137.9M 145.76M
Total Debt
56.99M 72M 85.66M 97.09M
Common Stock
73K 72K 71K 71K
Retained Earnings
-148.92M -822.65M -470.56M -238.76M
Comprehensive Income
-1.52M -441K -12.54M -1.2M
Shareholders Equity
1.54B 811.02M 1.1B 1.29B
Total Investments
1.46B 718.16M 957.73M 1.08B